MedElevator Войти в исследования
← Поиск публикаций

DOI 10.14218/jcth.2025.00621

Медицинская библиотека · Journal of clinical and translational hepatology · 2026

LDLR+ Monocytic Myeloid-derived Suppressor Cells Attenuate Allograft Rejection in Liver Transplantation.

Zhou Xin, Li Xinqiang, Jiang Peng, Li Shipeng, Jia Zhuoyu, Wang Xueteng, Cai Hailun, Liu Huan, Ding Ruidong, Cai Jinzhen

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: Liver transplant rejection significantly affects patient prognosis. Myeloid-derived suppressor cells (MDSCs), known for their potent immunoregulatory functions, represent a promising target for managing liver transplant rejection. This study aimed to systematically characterize the diversity of MDSC subsets and their context-dependent functions, particularly within the context of transplant tolerance.

METHODS

We analyzed clinical and murine liver transplants using single-cell RNA sequencing, bulk RNA sequencing, flow cytometry, multiplex immunohistochemistry, and co-culture assays to phenotype MDSC subsets.

RESULTS

Single-cell RNA sequencing analysis of human and murine samples revealed MDSC involvement in transplant rejection. In mice, MDSC scores followed a normal distribution during the first week post-transplant and correlated with clinical flow cytometry data at one month. A distinct LDLR+ monocytic MDSC (M-MDSC) subset was identified and confirmed through spatial mapping by multiplex immunohistochemistry. Flow cytometry demonstrated dynamic changes in LDLR+ M-MDSCs across tissues (liver, spleen, peripheral blood, bone marrow, and lymph nodes), with a peak during acute rejection. Co-culture experiments showed that LDLR-/- M-MDSCs exhibited reduced Arg-1/iNOS expression and an impaired capacity to induce inhibitory receptors (TIGIT, PD1, CTLA-4) or suppress effector molecules (GZMB, IFN-γ, IL-2) in CD8+ T cells.

CONCLUSIONS

These findings highlight the critical role of MDSCs in liver transplant rejection. LDLR+ M-MDSCs exhibited enhanced immunosuppressive properties, underscoring their potential clinical relevance in mitigating rejection and promoting immune tolerance.

Для цитирования: Zhou Xin, Li Xinqiang, Jiang Peng, Li Shipeng, Jia Zhuoyu, Wang Xueteng, Cai Hailun, Liu Huan, Ding Ruidong, Cai Jinzhen. LDLR+ Monocytic Myeloid-derived Suppressor Cells Attenuate Allograft Rejection in Liver Transplantation.. Journal of clinical and translational hepatology. 2026. DOI: 10.14218/jcth.2025.00621.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.